Fig. 1From: Blinatumomab therapy for B cell acute lymphoblastic leukemia accompanied by persistent or relapsed low-level MRD prior to hematopoietic stem cell transplantation in Chinese children: a case seriesVariations of MRD and fusion gene copy number in the three patients. MRD, minimal residual diseaseBack to article page